Vaccine Research Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast 2024-2028

Vaccine Research Market Size 2024-2028

The vaccine research market size is estimated to grow by USD 21.40 billion at a CAGR of 10.84% between 2023 and 2028. An important factor driving the growth of the global market is the research for novel adjuvants and vaccine delivery technologies to improve the efficacy and stability of vaccines. Adjuvants, which are used to improve the immune system response, are chemicals that are injected into vaccines. New adjuvants and dosage methods are under investigation to improve the immune response caused by vaccines. The immune response is strengthened by this highly focused delivery mechanism, which boosts the efficacy of the vaccine. Researchers are trying to improve vaccine formulations, enhance their efficacy, and possibly reduce the number of vaccines required for each person. Some of the prominent vaccine manufacturers include those specializing in pneumococcal vaccine, as well as vaccines for diphtheria-tetanus, HPV, MMR, rotavirus, influenza, hepatitis B, chickenpox, polio, BCG, and yellow fever. These developments will help meet the global demand for effective vaccinations against many infectious illnesses by enabling the production of more effective and potent vaccines.  

What will be the size of the Vaccine Research Market During the Forecast Period?

To learn more about this market report, Request Free Sample

Vaccine Research Market Segmentation

The vaccine research market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• End-User Outlook
  • Public
  • Private

• Age Group Outlook
  • Pediatric
  • Adult

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Argentina
    • Australia
    • Brazil

End-user analysis

Public

The market share growth by the public segment will be significant during the forecast period. Government organizations fall under the public end-user segment. Various government organizations are involved in the research of vaccines for infectious diseases, such as the US National Institute of Allergy and Infectious Disease (NIAID) and the US National Institutes of Health (NIH). The efforts taken by governments from around the world to develop and put into use a number of COVID-19 vaccines have resulted, in particular from massive and sustained investment which has been made over many decades.

Get a glance at the market contribution of various segments. View a PDF Sample

The public segment was valued at USD 12.10 billion in 2018. Governments have largely funded and invested in each and every aspect, starting from the basic science and pre-clinical development to the clinical trials for these vaccines. Based on a wide range of possible sources and the timing of data collection, it is significantly different in terms of estimates of actual government expenditure for the R&D of clinical trial supplies and COVID-19 vaccines.

Private

Private pharmaceutical companies have been at the forefront of discovering, developing, and delivering a range of effective vaccines to help prevent disease around the world for more than 100 years. Various vaccine R&D strategies, e.g. collaboration with governments, academics, and NGOs all over the world, are constantly being implemented by vendors. There has been a rise in private R&D spending on oncology clinical trials as well as the introduction of new vaccines. The outbreak of the COVID-19 pandemic has stimulated the R&D of vaccines to contain the COVID-19 pandemic. In addition to R&D spending by the private sector, governments across the world have provided support to the private sector to develop vaccines to contain the pandemic.

Age Group analysis

Pediatric

The pediatric age group is of high significance in the global market due to the sustained emphasis on the creation and delivery of vaccines for children. The health of children across the world has been greatly improved and as a result of the global vaccination programs for children, different infectious childhood diseases have been eradicated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. New vaccines to prevent diseases such as rotavirus and pneumococcal infections that cause high morbidity and mortality in children are also being developed. The emphasis on pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period.

Adult

The pediatric age group is of high significance in the global market due to the sustained emphasis on the creation and delivery of vaccines for children. Thanks to childhood vaccination programs in the world, children's health worldwide has greatly improved, and infectious diseases such as measles have been eliminated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. For diseases such as rotavirus or pneumococcal infections with high morbidity and mortality in children, new vaccines are also being developed. The emphasis on mono vaccines and pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period. 

Regional Analysis

For more insights about the market share of various regions, View PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America holds one of the largest shares of the global market, primarily due to the strong prevalence of infectious diseases, such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, and non-infectious diseases, such as cancer.  In developed countries in this region, the number of infectious and uninfectious diseases has been steadily increasing. Although there has been a gradual reduction in the number of infections caused by mumps, measles, and rubella MMR across the US, they are still not fully eradicated. Therefore, the government in the region, in collaboration with several private players, has worked toward the betterment of R&D to neutralize the impact of such infectious diseases. 

Request Free Sample

Vaccine Research Market Dynamics

The market encompasses the development, production, and distribution of various types of vaccines for immunization programs against clinical trials of diseases such as influenza, hepatitis B, chickenpox, polio, etc. These vaccines are designed to protect individuals from Allergies, Physiological disorders, Cancer, and other health conditions. Vaccine development involves the use of different technologies. Pregnant individuals during the gestational stage require specific vaccines to ensure the health of both mother and child. Therapeutic vaccines are also being researched for the treatment of diseases rather than prevention. Our researchers analyzed the data with 2023 as the base year, along with the key trends, and challenges. 

Key Market Driver

The high prevalence of infectious diseases is notably driving the market growth. Infectious diseases caused by microorganisms such as bacteria, viruses, and parasites, remain a significant global health concern. These pathogens can produce toxins and surface proteins that trigger various immune responses, leading to morbidity and mortality. In developing countries, the impact of infectious diseases is particularly severe due to limited healthcare infrastructure, resulting in high mortality rates, especially among children.

For instance, diseases like tetanus, pertussis, and measles continue to pose a threat, particularly in regions with inadequate vaccination efforts. In developed countries, infectious diseases continue to pose a challenge, with conditions like HIV, rotavirus, pneumococcal conjugate, and human papillomavirus (HPV) causing significant morbidity and economic burden. Next-generation vaccines, including mRNA vaccines, are being researched to address the evolving threat of infectious diseases. Private organizations and public health initiatives play a crucial role in vaccine research and development, ensuring the production of effective vaccines for various diseases, such as HPV, which is a leading cause of cervical cancer. The cold chain, a critical component of vaccine storage and distribution, ensures the efficacy and safety of vaccines, particularly for those requiring refrigeration like rotavirus vaccine. These factors are driving vaccine research market growth during the forecast period.

Significant Market Trends

The adoption of AI to speed up the R&D of vaccines is the primary trend in market drivers.  Artificial intelligence has the potential to lead to new vaccines being discovered and developed. AI helps convert data into valuable knowledge to understand the disease to be treated, design better clinical trials, and speed up the way we design and develop vaccines. To increase the productivity of R&D, AI tools assist vaccine researchers in their discovery of new biological insights.

Moreover, AI is also used for analyzing images in real-time and has helped researchers try to pick out genetic mutations and variations. This way, the virus can be identified with new variants and mutations. In this way, artificial intelligence can be a major tool for developing vaccines. Hence, the adoption of Ai in the R&D of vaccines is expected to be a significant trend driving vaccine research market growth during the forecast period.

Major Market Challenges

The high cost of vaccine research, development, and manufacturing is a major challenge in the market.  Vaccine development has a major role to play in the fight against many of the life-threatening diseases. Despite this achievement, there is still a great need for new vaccines. However, global achievements such as the eradication of smallpox have been slow due to the need for huge investments in the development and manufacture of vaccines. In order to develop vaccines that can contribute to the world's preparedness against and prevention of epidemics and pandemics caused by infection, a Consortium for Epidemiological Preparedness Innovations has been created under the name CEPI.

Moreover, the cost of vaccines is expected to be high for humans due to the costs involved in research, development, and manufacturing. The high cost of vaccines harms patient compliance and adherence to vaccine protocols, which limits market growth. Therefore, it has become important to develop vaccines with novel routes of administration coupled with low cost. Thus, the high cost of vaccine research, development, and manufacturing will impede vaccine research market growth during the forecast period.

Customer Landscape

The vaccine research market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the vaccine research market growth and forecasting market growth and trends report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Vaccine Research Market Customer Landscape

Key Vaccine Research Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth market report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories - The company offers vaccine research for therapy areas such as Anti incentives, Cardio Diabeto and Neuro Psychiat.

• Astellas Pharma Inc.
• AstraZeneca Plc
• Bavarian Nordic AS
• Bharat Biotech Ltd.
• CanSino Biologics Inc. 
• CSL Ltd.
• Daiichi Sankyo Co. Ltd.
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Merck and Co. Inc.
• Moderna Inc.
• Novavax Inc.
• Panacea Biotec Ltd.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Creative Biogene

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

Vaccine research is a dynamic and evolving field, focusing on the development of immunizations to prevent various diseases. This sector encompasses clinical trials, vaccine development, and research on self-antigens and adjuvants for therapeutic vaccines against cancer, allergies, physiological disorders, infectious diseases, hypertension, dyslipidemia, Alzheimer's, inflammatory diseases, and more. Animal studies play a crucial role in vaccine research, particularly in the development of conjugate vaccines, recombinant vaccines, live attenuated vaccines, toxoid vaccines, and vaccines for diseases like meningitis and pneumonia. Government immunization programs and preventive healthcare initiatives are key drivers in the vaccine market. Major vaccine manufacturers collaborate with genomic research centers to innovate and produce vaccines against diseases such as diphtheria, tetanus, HPV, MMR, rotavirus, influenza, hepatitis B, chickenpox, polio, BCG, and yellow fever.

The vaccine market is diverse and expansive, with ongoing research and development in various areas to address the needs of a growing and aging population. This includes the development of vaccines for diseases that have historically lacked effective preventive measures, such as Alzheimer's and certain inflammatory diseases. The ongoing advancements in vaccine research continue to provide hope for improved public health and disease prevention. The vaccine research market is advancing rapidly, driven by a focus on preventing lower respiratory tract disease and protecting various populations, including pregnant individuals. Key vaccines like pneumococcal vaccines, tetanus vaccines, HPV vaccines, MMR vaccines, rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, and polio vaccines play a crucial role in global immunization programs. The development of combination vaccines and monovaccines offers diverse protection against multiple diseases.

Vaccine development is evolving with new technologies, particularly in the creation of subunit, polysaccharide, live-attenuated vaccines, and inactivated vaccines. Therapeutic vaccines are also gaining attention as they aim to treat rather than prevent diseases, expanding the market's scope. Immunization programs continue to be vital for preventing widespread disease outbreaks. Pregnant individuals are increasingly prioritized in immunization programs due to their unique vulnerability. In particular, therapeutic vaccines for diseases like HPV and hepatitis B are essential in reducing maternal and neonatal infections. Continued research into live-attenuated vaccines and subunit vaccines ensures that both prevention and treatment options remain at the forefront of healthcare innovation. With ongoing vaccine development efforts, the market is set to address not only childhood diseases but also emerging global health threats across all populations.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Vaccine Research Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this vaccine research market research and growth report to meet your requirements. Get in touch